Aptargroup (ATR) Cash from Investing Activities (2009 - 2026)
Aptargroup's (ATR) quarterly Cash from Investing Activities came in at -$65.1 million in Q1 2026, down 14.95% year-on-year from -$76.5 million in Q1 2025, and up 44.03% on a QoQ basis from -$116.3 million in Q4 2025.
Aptargroup (ATR) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Aptargroup (ATR) has 18 years of Cash from Investing Activities data on file, last reported at -$65.1 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 14.95% year-over-year to -$65.1 million in Q1 2026; TTM through Mar 2026 was -$339.9 million, a 9.79% increase from a year earlier, with the FY2025 full-year figure at -$331.4 million, up 16.46% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$65.1 million, up from -$116.3 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for ATR reached as high as -$56.6 million in Q1 2025 and fell as low as -$171.1 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged -$83.1 million across 5 years, with a median of -$75.7 million in 2023.
- Across the five-year window, Cash from Investing Activities surged 59.64% in 2022 and tumbled 100.96% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at -$73.2 million in 2022, then dropped by 16.23% to -$85.1 million in 2023, then sank by 100.96% to -$171.1 million in 2024, then soared by 32.01% to -$116.3 million in 2025, then jumped by 44.03% to -$65.1 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$65.1 million in Q1 2026, -$116.3 million in Q4 2025, and -$89.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Aptargroup | 8.56 Bn | 8.33 Bn | 351.91 Mn | -65.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.10 Mn |
| Mar 31, 2026 | -65.10 Mn |
| Dec 31, 2025 | -116.31 Mn |
| Dec 31, 2025 | -116.31 Mn |
| Sep 30, 2025 | -89.05 Mn |
| Sep 30, 2025 | -89.05 Mn |
| Jun 30, 2025 | -69.44 Mn |
| Jun 30, 2025 | -69.44 Mn |
| Mar 31, 2025 | -56.63 Mn |
| Mar 31, 2025 | -56.63 Mn |
| Dec 31, 2024 | -171.07 Mn |
| Dec 31, 2024 | -171.07 Mn |
| Sep 30, 2024 | -80.67 Mn |
| Sep 30, 2024 | -80.67 Mn |
| Jun 30, 2024 | -68.41 Mn |
| Jun 30, 2024 | -68.41 Mn |
| Mar 31, 2024 | -76.57 Mn |
| Mar 31, 2024 | -76.57 Mn |
| Dec 31, 2023 | -85.13 Mn |
| Dec 31, 2023 | -85.13 Mn |